Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Marc Leger

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Clinical and Experimental Rheumatology|June 30, 2015
Long-term outcome of infliximab in severe chronic and refractory systemic sarcoidosis: a report of 16 casesCatherine Chapelon-Abric, David Saadoun, Lucie Biard, et al.
Annals of the Rheumatic Diseases|May 16, 2012
Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas surveyBenjamin Terrier, Fabrice Carrat, Evguenia Krastinova, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Clinical and Experimental Rheumatology|June 30, 2015
Long-term outcome of infliximab in severe chronic and refractory systemic sarcoidosis: a report of 16 casesCatherine Chapelon-Abric, David Saadoun, Lucie Biard, et al.
Annals of the Rheumatic Diseases|May 16, 2012
Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas surveyBenjamin Terrier, Fabrice Carrat, Evguenia Krastinova, et al.
Pageof 2